Company Information
USD
115.71
- (-1.5%)
NASDAQ:NBIX, NEUROCRINE BIOSCIENCES, INC.
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 9 May 2025 GMT-4
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Address
12780 El Camino Real
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - Specialty & Generic
Key Executives
Mr. Gary A. Lyons
Director
Dr. Kevin C. Gorman,PhD
CEO/Director
Mr. Richard F. Pops
Director
Ms. Shalini Sharp
Director
Dr. William H. Rastetter,PhD
Chairman of the Board/Director
Ms. Christine A. Poon
Director
Mr. George J. Morrow
Director
Dr. Stephen A. Sherwin, M.D.
Director
Ms. Leslie V. Norwalk, Esq.
Director
Mr. Matthew C. Abernethy
CFO/Chief Accounting Officer
Dr. Eiry W. Roberts, M.D.
Chief Medical Officer
Ms. Johanna Mercier
Director
Mr. Eric S. Benevich
Other Executive Officer
Mr. Darin M. Lippoldt
Chief Legal Officer/Secretary
Dr. Kyle W. Gano, PhD
Chief Strategy Officer/Other Executive Officer
Ms. Julie S. Cooke
Other Executive Officer
Mr. David W. Boyer
Other Executive Officer
Dr. Jude Onyia, PhD
Chief Scientific Officer
Ms. Ingrid Delaet
Other Executive Officer
Ownership
Institution Holdings
BlackRock Inc
13,647,891 (13.715%)
Vanguard Group Inc
9,710,328 (9.758%)
BlackRock Fund Advisors
6,831,079 (6.865%)
State Street Corporation
4,063,336 (4.083%)
Vanguard Investments Australia Ltd
3,158,618 (3.174%)
Bellevue Asset Management AG
2,586,550 (2.599%)
Point72 Asset Management, L.P.
2,578,128 (2.591%)
Bellevue Group AG
2,430,500 (2.443%)
Morgan Stanley - Brokerage Accounts
2,326,294 (2.338%)
Renaissance Technologies Corp
1,988,546 (1.998%)
Individual Holdings
Dr. Kevin C. Gorman,PhD
514,596 (0.517%)
John J. O'Connor
118,256 (0.216%)
Mr. Gary A. Lyons
193,697 (0.197%)
Dr. Kyle W. Gano, PhD
135,166 (0.136%)
Obrien Christopher Flint
55,946 (0.063%)
Dr. William H. Rastetter,PhD
51,741 (0.052%)
Mr. Eric S. Benevich
40,616 (0.041%)
Mr. Darin M. Lippoldt
39,740 (0.040%)
Mr. Matthew C. Abernethy
31,528 (0.032%)
Mr. Richard F. Pops
29,512 (0.030%)
Funds Holdings
Vanguard Total Stock Market Index Fund
3,109,007 (3.124%)
Vanguard US Total Market Shares ETF
3,109,007 (3.124%)
iShares Core S&P Mid-Cap ETF
2,990,996 (3.006%)
BB Biotech AG
2,554,350 (2.567%)
Vanguard Small Cap Index
2,509,019 (2.521%)
Vanguard Institutional Extnd Mkt Idx Tr
1,449,963 (1.457%)
Vanguard Small Cap Growth Index Fund
1,399,150 (1.406%)
SPDR® S&P MIDCAP 400 ETF Trust
781,790 (0.786%)
iShares MSCI USA Min Vol Factor ETF
751,842 (0.756%)
iShares Biotechnology ETF
729,348 (0.733%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
